News

GRID VIEW

No more posts

Osteoarthritis-Knee-Pain-Research-2.jpg

March 25, 2026 Jason Crane


Obesity and Osteoarthritis of the Knee Research

Qualified volunteers may receive at no cost:

  • Investigational medications

  • Study-related medical care from a qualified doctor

  • Possible compensation for time and travel

No health insurance is required to participate in our studies.

 

View the criteria for each location by clicking the dropdown below, or sign up at the bottom, and our team will contact you directly.


  • Jacksonville: Westside – Osteoarthritis Knee Pain and Weight Research Study
  • Jacksonville: Westside – OA & Obesity (YDAN)
Jacksonville: Westside – Osteoarthritis Knee Pain and Weight Research Study

Are you living with knee pain from osteoarthritis and struggling to manage your weight?  

Westside Center for Clinical Research is testing an investigational treatment designed to help adults with knee arthritis who are overweight or obese. 

Osteoarthritis is a common condition that can cause: 

  • Aching or stiff knees, especially in the morning 
  • Pain with movement, walking, or climbing stairs 
  • Swelling or grinding/clicking sensations 
  • Limited knee mobility 

Excess weight can make knee pain worse and make it harder to stay active or lose weight. This study offers expert care, monitoring, and nutrition support to participants while testing a new treatment. 

Who Can Participate 

You may be eligible if you: 

  • Are 18 years or older 
  • Have a BMI of 27 or higher (overweight or obese) 
  • Have chronic knee pain from osteoarthritis lasting 3 months or more 
  • Experience knee pain on most days (at least 15 days per month) 
  • Have moderate knee pain  
  • Have tried diet-based weight loss without long-term success 

Note: Participants cannot have diabetes and must maintain a stable body weight. 

Jacksonville: Westside – OA & Obesity (YDAN)

Are you dealing with chronic knee pain from arthritis and struggling with your weight?

Join a research study.

If you’ve been living with chronic knee pain from osteoarthritis and struggling with your weight, you may be eligible for a research study.

This study is testing an investigational treatment for adults ages 18 and older with knee pain from osteoarthritis and a BMI of 27 or higher (overweight or obese).

You may qualify if you:

  • Are 18 years of age or older
  • Have a BMI of 27 or higher
  • Have knee pain from osteoarthritis for at least 3 months
  • Do not have diabetes

Why Participate?

  • Access to investigational treatment
  • Expert care and monitoring
  • Regular knee assessments and X-rays
  • Nutrition counseling with a dietitian
  • No cost for study-related care, tests, and investigational treatment
  • Compensation may be available

See if you qualify today.

For more information or to see if you qualify, contact our research office. 

Image attached to this email, thanks!




  • Fleming Island
  • Jacksonville Borland Groover
  • Jacksonville University Blvd.
  • Jacksonville Westside
  • Nature Coast – Crystal River
  • Nature Coast – Inverness
  • St. Augustine
Fleming Island
Jacksonville Borland Groover
Jacksonville University Blvd.
Jacksonville Westside
Nature Coast – Crystal River
Nature Coast – Inverness
St. Augustine


This research study is enrolling at:


Westside Center for Clinical Research
810 Lane Avenue South
Jacksonville, FL 32205
(904) 693-1490



Fleming Island Center for Clinical Research
1679 Eagle Harbor Parkway
Suite D, 2nd Floor Fleming Island, FL 32003
(904) 621-0390



Jacksonville Center for Clinical Research
4085 University Blvd., South
Suite 1
Jacksonville, FL 32216
(904) 730-0166



St. Johns Center for Clinical Research
100 Whetstone Place,
Suites 300 – 301,
St. Augustine, FL 32086

(904) 209-0043



ENCORE Borland Groover Clinical Research
4800 Belfort Road, Suite 301
Jacksonville, FL 32256
(904) 680-0871



Westside Center for Clinical Research
810 Lane Avenue South
Jacksonville, FL 32205
(904) 693-1490



Nature Coast Clinical Research – Inverness
411 West Highland Boulevard
Inverness, FL 34452
(352) 341-2100



Nature Coast Clinical Research – Crystal River
6122 West Corporate Oaks Drive
Crystal River, FL 34429
(352) 861-1865



Sign up below to join our research studies and make a difference!

Sign up below to join our research studies and make a difference!


8.jpg

January 6, 2023 Rebecca Simpson

human heart


    Do you or someone you know have Cardiovascular Disease?

    Qualified volunteers may receive at no cost:

    • Investigational medications

    • Study-related medical care from a qualified doctor

    • Possible compensation for time and travel

    No health insurance is required to participate in our studies.

    View the criteria for each location by clicking the dropdown below, or sign up at the bottom, and our team will contact you directly.


    • Fleming Island: Atherosclerotic Cardiovascular Disease (ASCVD)
    • Jacksonville (University) – Study (JAGUAR)
    • Jacksonville: University Blvd – ASCVD/CVOT
    • Jacksonville: University Blvd – Moderate Calcific Aortic Valve Stenosis
    • Jacksonville: Westside – Atherosclerotic Cardiovascular Disease (ASCVD)
    • Jacksonville: Westside – Hypertension
    • St. Augustine – Atherosclerotic Cardiovascular Disease (ASCVD)
    • St. Augustine – Moderate Calcific Aortic Valve Stenosis
    • St. Augustine – Study (MARITIME-ASCVD)
    Fleming Island: Atherosclerotic Cardiovascular Disease (ASCVD)

    Join a Research Study for Cardiovascular Disease!

     

    To qualify, you must:

    • Be 18 years or older
    • Have experienced at least one of the following Cardiovascular events:
      • A Heart Attack
      • A Large Artery Ischemic Stroke within the last year
      • Revascularization procedure due to symptomatic Peripheral Artery Disease
    • Have at least one of the following conditions/factors:
      • Type 2 Diabetes
      • Aged 65 or older
      • Multivessel Disease
      • Additional previous Heart Attack
      • Stage A, B or C Chronic Kidney Disease (CKD)
      • Lower extremity revascularization due to poor circulation or to treat a large vessel ischemic stroke
    • On a stable dose of maximum-tolerated Statin for at least a month

    Please note additional criteria will apply

    Study Location: Fleming Island, FL

    Jacksonville (University) – Study (JAGUAR)

    What is an abdominal aortic aneurysm?

    An abdominal aortic aneurysm (AAA) is a bulge in the aorta (the main artery leaving the heart) caused by a weakening in the artery wall. If left untreated, this bulge may continue to grow and possibly rupture (break open), causing serious internal bleeding.

    If you or someone you know has AAA, you may qualify for our research study.

    See if you qualify today!

    Call 904-230-0166

    Jacksonville: University Blvd – ASCVD/CVOT

    Join a Research Study for Cardiovascular Disease!

     

    To qualify, you must:

    • Be 18 years or older
    • Have experienced at least one of the following Cardiovascular events:
      • A Heart Attack
      • A Large Artery Ischemic Stroke within the last year
      • Revascularization procedure due to symptomatic Peripheral Artery Disease
    • Have at least one of the following conditions/factors:
      • Type 2 Diabetes
      • Aged 65 or older
      • Multivessel Disease
      • Additional previous Heart Attack
      • Stage A, B or C Chronic Kidney Disease (CKD)
      • Lower extremity revascularization due to poor circulation or to treat a large vessel ischemic stroke
    • On a stable dose of maximum-tolerated Statin for at least a month

    Please note additional criteria will apply

    Study Location: Jacksonville, FL

    Jacksonville: University Blvd – Moderate Calcific Aortic Valve Stenosis

    KAR-ATA-301 KATALYST-AV

         Purpose of the Study:

    • This study is testing an investigational medication to:
    • Slow the buildup of calcium on the aortic valve
    • Slow worsening of aortic valve narrowing
    • Improve heart function and exercise ability

        Who Can Join This Study:

    • You may be able to take part if you:
    • Are 50 years or older
    • Have moderate calcific aortic valve stenosis (CAVS)
    • Have not had prior aortic valve replacement or repair
    • Have heart function above a certain level
    • Are able to complete study testing (like exercise testing)

    Jacksonville: Westside – Atherosclerotic Cardiovascular Disease (ASCVD)

     

    New Cardiovascular Research Study Now Enrolling 

    Westside Center for Clinical Research is currently seeking volunteers for a new clinical research study focused on Atherosclerotic Cardiovascular Disease (ASCVD). This study is designed for adults who have experienced a recent cardiovascular event and are currently taking a statin medication. 

    About This Study 

    Cardiovascular disease remains one of the leading causes of serious health complications worldwide. This research study is evaluating potential approaches that may help improve outcomes for people living with ASCVD who are already receiving statin therapy. 

    Researchers are looking to better understand how new therapies may support individuals who have experienced significant cardiovascular events. 

    Your participation could help researchers learn more about improving heart health and preventing future complications. 

    Who May Qualify 

    You may be eligible to participate if you: 

    • Are an adult 18 years of age or older  
    • Have experienced one of the following cardiovascular events within the last year: 
      • Heart attack 
      • Large artery ischemic stroke 
      • A revascularization procedure due to symptomatic peripheral artery disease 
    • Are currently taking a stable dose of a statin medication 
    • Are on a maximum tolerated dose of statin therapy 

    Jacksonville: Westside – Hypertension

    New Cardiovascular Research Study Now Enrolling 

    Westside Center for Clinical Research is looking at how certain medications can help people with kidney disease or type 2 diabetes (T2DM). The research focuses on how these medicines may: 

    • Slow the progression of kidney disease 
    • Reduce the risk of heart-related problems 
    • Help manage blood sugar levels in children, teens, and adults with T2DM 

    Who Can Participate 

    • Adults with chronic kidney disease (CKD), with or without diabetes 
    • Children and adolescents with type 2 diabetes, especially if they are taking or cannot tolerate metformin or insulin

    St. Augustine – Atherosclerotic Cardiovascular Disease (ASCVD)

    New Cardiovascular Research Study Now Enrolling 

    St. Johns Center for Clinical Research are currently seeking volunteers for a new clinical research study focused on Atherosclerotic Cardiovascular Disease (ASCVD). This study is designed for adults who have experienced a recent cardiovascular event and are currently taking a statin medication. 

    About This Study 

    Cardiovascular disease remains one of the leading causes of serious health complications worldwide. This research study is evaluating potential approaches that may help improve outcomes for people living with ASCVD who are already receiving statin therapy. 

    Researchers are looking to better understand how new therapies may support individuals who have experienced significant cardiovascular events. 

    Your participation could help researchers learn more about improving heart health and preventing future complications. 

    Who May Qualify 

    You may be eligible to participate if you: 

    • Are an adult 18 years of age or older  
    • Have experienced one of the following cardiovascular events within the last year: 
      • Heart attack 
      • Large artery ischemic stroke 
      • A revascularization procedure due to symptomatic peripheral artery disease 

     

    St. Augustine – Moderate Calcific Aortic Valve Stenosis

     

    KAR-ATA-301 KATALYST-AV

     

    Purpose of the Study:

    • This study is testing an investigational medication to:
    •  Slow the buildup of calcium on the aortic valve
    • Slow worsening of aortic valve narrowing
    • Improve heart function and exercise ability

     

    Who Can Join This Study?

    • You may be able to take part if you:
    • Are 50 years or older
    • Have moderate calcific aortic valve stenosis (CAVS)
    • Have not had prior aortic valve replacement or repair
    • Have heart function above a certain level
    • Are able to complete study testing (like exercise testing)

    St. Augustine – Study (MARITIME-ASCVD)

    45+ with a History of Heart Attack or Stroke? 

    You may qualify for a new research study at St. John’s Center for Clinical Research focused on improving the future of cardiovascular care. 

    If you’re living with heart disease, prior heart attack, or stroke, and are also managing weight challenges, this study may be an opportunity to explore new approaches to treatment—while helping advance medical research. 

    About the Study 

    This cardiovascular research study is designed for adults who have experienced a heart attack or stroke and are currently overweight or obese. 

    Researchers are working to better understand how to improve outcomes and develop future treatment options for individuals with cardiovascular conditions. 

    By participating, you’ll play an important role in helping advance heart health research for future generations. 
     Who May Qualify? 

    You may be eligible to participate if you: 

    ✅ Are 45 years of age or older
    ✅ Have a history of heart attack or stroke
    ✅ Have a BMI of 27 or higher(overweight or obese)  

     



    This research study is enrolling at:


    Fleming Island Center for Clinical Research
    1679 Eagle Harbor Parkway
    Suite D, 2nd Floor Fleming Island, FL 32003
    (904) 621-0390



    Jacksonville Center for Clinical Research
    4085 University Blvd., South
    Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    St. Johns Center for Clinical Research
    100 Whetstone Place,
    Suites 300 – 301,
    St. Augustine, FL 32086

    (904) 209-0043



    Westside Center for Clinical Research
    810 Lane Avenue South
    Jacksonville, FL 32205
    (904) 693-1490



    Nature Coast Clinical Research – Crystal River
    6122 West Corporate Oaks Drive
    Crystal River, FL 34429
    (352) 861-1865



    Fleming Island Center for Clinical Research
    1679 Eagle Harbor Parkway
    Suite D, 2nd Floor Fleming Island, FL 32003
    (904) 621-0390



    Jacksonville Center for Clinical Research
    4085 University Blvd., South
    Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    St. Johns Center for Clinical Research
    100 Whetstone Place,
    Suites 300 – 301,
    St. Augustine, FL 32086

    (904) 209-0043



    ENCORE Borland Groover Clinical Research
    4800 Belfort Road, Suite 301
    Jacksonville, FL 32256
    (904) 680-0871



    Westside Center for Clinical Research
    810 Lane Avenue South
    Jacksonville, FL 32205
    (904) 693-1490



    Nature Coast Clinical Research – Inverness
    411 West Highland Boulevard
    Inverness, FL 34452
    (352) 341-2100



    Nature Coast Clinical Research – Crystal River
    6122 West Corporate Oaks Drive
    Crystal River, FL 34429
    (352) 861-1865



    Sign up below to join our research studies and make a difference!

    Sign up below to join our research studies and make a difference!


    Flu-Study.png

    July 29, 2021 Rebecca Simpson


    Interested in participating in a Flu Vaccine Research Study?

    Qualified volunteers may receive at no cost:

    • Investigational medications

    • Study-related medical care from a qualified doctor

    • Possible compensation for time and travel

    No health insurance is required to participate in our studies.

    View the criteria for each location by clicking the dropdown below, or sign up at the bottom, and our team will contact you directly.



    • Jacksonville: Westside – Flu Vaccine COMING SOOON!
    Jacksonville: Westside – Flu Vaccine COMING SOOON!

    GSK 218130 Flu Vax Age 65+

    About this study:

    The purpose of this study is to learn how safe and effective an investigational influenza (flu) vaccine is in adults 65 years of age and older.

    Basic Eligibility:

    To participate, you must:

    • Be 65 years of age or older at the time you receive the study vaccine.
    • Not have had a confirmed influenza infection within the past 180 days.

    The study team will review your medical history and current health to determine whether the study is a good fit for you.

    Why participate?

    •  Help advance research in heart disease prevention
    • Compensation may be available (if applicable)

    Study Details: 

    Location: Jacksonville, FL 

    All study- related care is provided at no cost to you or your insurance company.



    • Fleming Island
    • Jacksonville Borland Groover
    • Jacksonville University Blvd.
    • Jacksonville Westside
    • Nature Coast – Crystal River
    • Nature Coast – Inverness
    • St. Augustine
    Fleming Island
    Jacksonville Borland Groover
    Jacksonville University Blvd.
    Jacksonville Westside
    Nature Coast – Crystal River
    Nature Coast – Inverness
    St. Augustine


    This research study is enrolling at:


    Westside Center for Clinical Research
    810 Lane Avenue South
    Jacksonville, FL 32205
    (904) 693-1490



    BELOW ARE HIDDEN ROWS

    Fleming Island Center for Clinical Research
    1679 Eagle Harbor Parkway
    Suite D, 2nd Floor Fleming Island, FL 32003
    (904) 621-0390



    Jacksonville Center for Clinical Research
    4085 University Blvd., South
    Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    St. Johns Center for Clinical Research
    100 Whetstone Place,
    Suites 300 – 301,
    St. Augustine, FL 32086

    (904) 209-0043



    ENCORE Borland Groover Clinical Research
    4800 Belfort Road, Suite 301
    Jacksonville, FL 32256
    (904) 680-0871



    Westside Center for Clinical Research
    810 Lane Avenue South
    Jacksonville, FL 32205
    (904) 693-1490



    Nature Coast Clinical Research – Inverness
    411 West Highland Boulevard
    Inverness, FL 34452
    (352) 341-2100



    Nature Coast Clinical Research – Crystal River
    6122 West Corporate Oaks Drive
    Crystal River, FL 34429
    (352) 861-1865



    Sign up below to join our research studies and make a difference!


    Volunteers.jpg

    April 28, 2020 Rebecca Simpson


    Are you healthy? You can still make a difference!

    Qualified volunteers may receive at no cost:

    • Investigational medications

    • Study-related medical care from a qualified doctor

    • Possible compensation for time and travel

    No health insurance is required to participate in our studies.



    • Fleming Island
    • Jacksonville Borland Groover
    • Jacksonville University Blvd.
    • Jacksonville Westside
    • Nature Coast – Crystal River
    • Nature Coast – Inverness
    Fleming Island
    Jacksonville Borland Groover
    Jacksonville University Blvd.
    Jacksonville Westside
    Nature Coast – Crystal River
    Nature Coast – Inverness


    This research study is enrolling at:


    Jacksonville Center for Clinical Research
    4085 University Blvd., South
    Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    Nature Coast Clinical Research – Crystal River
    6122 West Corporate Oaks Drive
    Crystal River, FL 34429
    (352) 563-1865



    Nature Coast Clinical Research – Inverness
    411 West Highland Boulevard
    Inverness, FL 34452
    (352) 341-2100



    Westside Center for Clinical Research
    810 Lane Avenue South
    Jacksonville, FL 32205
    (904) 693-1490



    BELOW ARE HIDDEN ROWS

    Fleming Island Center for Clinical Research
    1679 Eagle Harbor Parkway
    Suite D, 2nd Floor Fleming Island, FL 32003
    (904) 621-0390



    Jacksonville Center for Clinical Research
    4085 University Blvd., South
    Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    St. Johns Center for Clinical Research
    100 Whetstone Place,
    Suites 300 – 301,
    St. Augustine, FL 32086

    (904) 209-0043



    ENCORE Borland Groover Clinical Research
    4800 Belfort Road, Suite 301
    Jacksonville, FL 32256
    (904) 680-0871



    Westside Center for Clinical Research
    810 Lane Avenue South
    Jacksonville, FL 32205
    (904) 693-1490



    Nature Coast Clinical Research – Inverness
    411 West Highland Boulevard
    Inverness, FL 34452
    (352) 341-2100



    Nature Coast Clinical Research – Crystal River
    6122 West Corporate Oaks Drive
    Crystal River, FL 34429
    (352) 861-1865



    Sign up below to join our research studies and make a difference!


    Blood-Pressure.jpg

    June 1, 2021 Rebecca Simpson

    Blood Pressure Research

    Do you or someone you know have High Blood Pressure?

    Qualified volunteers may receive at no cost:

    • Investigational medications

    • Study-related medical care from a qualified doctor

    • Possible compensation for time and travel

    No health insurance is required to participate in our studies.

    View the criteria for each location by clicking the dropdown below, or sign up at the bottom, and our team will contact you directly.


    • Crystal River – Study (Pacemaker – Backbeat)
    • Jacksonville – Study (KAR)
    • Fleming Island – High Blood Pressure & Heart Health Research Study
    • Jacksonville: Westside – High Blood Pressure – Hypertension (Zenith)
    • Jacksonville: University Blvd – High Blood Pressure – Hypertension (Zenith)
    • Jacksonville: University Blvd – Uncontrolled Hypertension (CRSPR)
    Crystal River – Study (Pacemaker – Backbeat)

    Jacksonville – Study (KAR)

    Fleming Island – High Blood Pressure & Heart Health Research Study

    Help Advance Research for High Blood Pressure and Heart Disease 

    Fleming Island Center for Clinical Research is currently enrolling volunteers for a clinical research study for adults with high blood pressure (hypertension). 

    This study is evaluating a potential new treatment that may help improve heart health and reduce the risk of serious cardiovascular events such as heart attacks or strokes. 

    By joining this study, you may help researchers learn more about new ways to better manage high blood pressure and protect heart health in the future. 

    No insurance is required to participate. 
    Study-related care will be provided at no cost. 

    Who May Qualify 

    You may be eligible to participate if you: 

    • Are 18 years or older and have a history of heart or cardiovascular disease 
      OR 
    • Are 55 years or older and may be at higher risk for heart disease 
    • Have been diagnosed with high blood pressure 
    • Your blood pressure may not be fully controlled with your current treatment 

    Jacksonville: Westside – High Blood Pressure – Hypertension (Zenith)

    Diagnosed with Cardiovascular Disease?

    Research study for adults diagnosed with Heart Disease or at very high risk for Cardiovascular Disease now enrolling at Westside Center for Clinical Research. Qualified participants must be on two types of medication to manage High Blood Pressure.

    Basic Criteria:

    • Be 18 years or older and diagnosed with Heart Disease OR be 40 years or older and at very high risk for Cardiovascular Disease
    • Be on two forms of stable medication for High Blood Pressure for at least 1 month

    Why Participate?

    • Potential Access to Cutting Edge Treatments: Be among the first to gain exposure to new cardiovascular therapies under development.
    • Comprehensive Support, No Insurance Required: All study-related care, including lab work and tests, will be provided at no cost to you.
    • Compensation May Be Available for Time & Travel: We value your contribution and offer compensation for your time, efforts, and travel.
    • Advance Medical Discoveries: Your participation could help improve treatment options for future generations around the world.

    No insurance is necessary.

    Receive study-related care at no cost.

    Sign up for a call from our staff on the form below.

    Jacksonville: University Blvd – High Blood Pressure – Hypertension (Zenith)

    Diagnosed with Cardiovascular Disease?

    Research study for adults diagnosed with Heart Disease or at very high risk for Cardiovascular Disease now enrolling at Jacksonville Center for Clinical Research. Qualified participants must be on two types of medication to manage High Blood Pressure.

    Basic Criteria:

    • Be 18 years or older and diagnosed with Heart Disease OR be 40 years or older and at very high risk for Cardiovascular Disease
    • Be on two forms of stable medication for High Blood Pressure for at least 1 month

    Why Participate?

    • Potential Access to Cutting Edge Treatments: Be among the first to gain exposure to new cardiovascular therapies under development.
    • Comprehensive Support, No Insurance Required: All study-related care, including lab work and tests, will be provided at no cost to you.
    • Compensation May Be Available for Time & Travel: We value your contribution and offer compensation for your time, efforts, and travel.
    • Advance Medical Discoveries: Your participation could help improve treatment options for future generations around the world.

    No insurance is necessary.

    Receive study-related care at no cost.

    Sign up for a call from our staff on the form below.

    Jacksonville: University Blvd – Uncontrolled Hypertension (CRSPR)

    The study information below is from Clinicaltrials.gov.

    https://clinicaltrials.gov/study/NCT07758634?term=CVD-402&viewType=Card&rank=1

    Brief Summary

    A Study of CTX340 in Participants with Uncontrolled Hypertension.

    Official Title:

    A Phase 1/2 Multicenter, First-in-human, Ascending Dose Trial Evaluating the Safety, Tolerability, and Efficacy of a Lipid Nanoparticle Formulation of CRISPR-Guide RNA-Cas9 Nuclease (CTX340) for In Vivo Editing of the Angiotensinogen (AGT) Gene in Participants With Hypertension

    Eligibility Criteria

    Inclusion Criteria:

    • Age: ≥18 and ≤75 years.
    • Body mass index ≤40 kg/m2.
    • 24-hour mean ambulatory blood pressure monitoring (ABPM) systolic blood pressure (SBP) measurement of ≥130 mm Hg but ≤160 mm Hg despite treatment
    • Be on treatment with ≥4 antihypertensive therapies at effective doses, of which ≥1 must be a diuretic.
    • Participants who at any point had childbearing potential must currently be postmenopausal
    • All participants capable of producing sperm must agree to the use of an acceptable method of effective contraception and their partners with childbearing potential should also agree to use an effective method of contraception.

    Exclusion Criteria:

    • Serum aldosterone and direct renin concentration (or plasma renin activity [PRA]) suggestive of primary aldosteronism
    • Mean diastolic blood pressure (DBP) ≤65 mm Hg on screening ABPM.
    • Participants with vascular cause of hypertension which may be amendable to revascularization
    • Participants with treatable/reversible causes of uncontrolled hypertension
    • History of renal artery denervation within past 12 months.
    • Orthostatic hypotension
    • Complete blood count (CBC) outside the specified ranges per protocol.
    • Evidence of liver disease
    • History of a significant coagulation disorder.
    • Uncontrolled or untreated thyroid disease

    For more information about this study, please call our research office.



    High Blood Pressure research is enrolling at:


    Fleming Island Center for Clinical Research
    1679 Eagle Harbor Parkway
    Suite D, 2nd Floor Fleming Island, FL 32003
    (904) 621-0390



    Jacksonville Center for Clinical Research
    4085 University Blvd., South
    Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    Nature Coast Clinical Research – Crystal River
    6122 West Corporate Oaks Drive
    Crystal River, FL 34429
    (352) 563-1865



    Westside Center for Clinical Research
    810 Lane Avenue South
    Jacksonville, FL 32205
    (904) 693-1490



    BELOW ARE HIDDEN ROWS

    Fleming Island Center for Clinical Research
    1679 Eagle Harbor Parkway
    Suite D, 2nd Floor Fleming Island, FL 32003
    (904) 621-0390



    Jacksonville Center for Clinical Research
    4085 University Blvd., South
    Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    St. Johns Center for Clinical Research
    100 Whetstone Place,
    Suites 300 – 301,
    St. Augustine, FL 32086

    (904) 209-0043



    ENCORE Borland Groover Clinical Research
    4800 Belfort Road, Suite 301
    Jacksonville, FL 32256
    (904) 680-0871



    Westside Center for Clinical Research
    810 Lane Avenue South
    Jacksonville, FL 32205
    (904) 693-1490



    Sign up below to join our research studies and make a difference!

    Sign up below to join our research studies and make a difference!



    Lipoprotein.jpg

    January 30, 2020 Rebecca Simpson

    Lipoprotein(a) - Lp(a)


      Do you or someone you know have High Cholesterol? You may have elevated Lp(a). Find out today!

      Qualified volunteers may receive at no cost:

      • Investigational medications

      • Study-related medical care from a qualified doctor

      • Possible compensation for time and travel

      No health insurance is required to participate in our studies.

      View the criteria for each location by clicking the dropdown below, or sign up at the bottom, and our team will contact you directly.



      • Jacksonville: University Blvd – Lp(a) – OCEAN(a)-CCTA
      • Jacksonville: University Blvd – Heart Disease + High Lp(a)
      • Jacksonville: University Blvd – OCEAN(a)-PreEvent – Lp(a)
      • Jacksonville: University Blvd – ACCLAIM-CTA – Lp(a)
      • Jacksonville: Westside – High Lp(a)
      • Nature Coast: Inverness – High Lp(a)
      Jacksonville: University Blvd – Lp(a) – OCEAN(a)-CCTA

      Cardiovascular Disease Research Study

      Testing investigational treatment for adults with history of heart attack or heart stent and elevated lipoprotein(a)

      If you have a history of heart attack or heart stent placement and elevated lipoprotein(a) levels, you may be eligible for a cardiovascular research study. This study is testing an investigational treatment for adults ages 35-80 with stable coronary artery disease and elevated Lp(a) ≥200 nmol/L.

      Coronary artery disease (CAD) affects millions of adults and occurs when plaque builds up in the arteries that supply blood to the heart. This plaque buildup narrows the arteries and reduces blood flow to the heart muscle, which can lead to chest pain (angina), shortness of breath, heart attacks, and other serious complications. Many people with coronary artery disease have had a heart attack (myocardial infarction) or have received heart stents to open blocked arteries.

      Lipoprotein(a), or Lp(a), is a type of cholesterol particle in your blood that is largely determined by your genes (inherited from your parents). High Lp(a) levels significantly increase your risk of

      heart disease, heart attacks, and stroke, even if your regular cholesterol levels (LDL and HDL) are well-controlled with medications like statins. Unlike regular cholesterol, Lp(a) levels don’t respond well to diet, exercise, or standard cholesterol medications. Currently, there are limited treatment options specifically targeting Lp(a).

      This study (OCEAN(a)-CCTA) is evaluating the safety, tolerability, and effect of an investigational treatment (olpasiran) on coronary artery plaque burden as measured by advanced heart imaging called coronary computed tomography angiography (CCTA). It will be administered as an injection once every 12 weeks (quarterly) at the study site by trained study staff for approximately 18-20 months. You’ll receive expert cardiovascular care and monitoring, including coronary CT scans at the beginning and end of the study to measure changes in plaque buildup in your coronary arteries.

      Important: You must have a history of heart attack (myocardial infarction) and/or heart stent placement (percutaneous coronary intervention or PCI), and your coronary CT scan must show coronary artery disease with at least 20% narrowing in at least one major vessel. Study-related care, tests, and investigational treatment are provided at no cost. Compensation may be available.

       

      You may qualify if you:

      • Are between 35 and 80 years old
      • Have a history of heart attack (myocardial infarction) and/or heart stent placement (PCI)
      • Have elevated lipoprotein(a) levels (Lp(a) ≥200 nmol/L) – will be tested during screening
      • Have coronary artery disease visible on CT scan (at least 20% narrowing in at least one major vessel)
      • Have been on stable cholesterol-lowering medications for at least 2 weeks
      • Are willing to attend study visits every 12 weeks for injections
      • Are willing to have coronary CT scans at the beginning and end of the study
      • Are in stable condition (no recent heart attack or stent in past 3 months, no acute coronary syndrome in past 12 months)

       

      Study Location: Jacksonville, FL – University Blvd.

      Sign up below and someone from our office will call you with more information.

      Jacksonville: University Blvd – Heart Disease + High Lp(a)

      Adults with Heart Disease and Elevated Lp(a) Needed for Cardiovascular Research Study

      Are you an adult with a history of heart disease? is conducting a clinical research study testing an investigational treatment to reduce Lp(a), a genetic cholesterol risk factor associated with increased cardiovascular risk.

      About the Study:

      This is a Phase 2 research study evaluating the safety and effectiveness of investigational treatment, an investigational treatment designed to reduce elevated Lipoprotein(a) [Lp(a)] levels. Lp(a) is a genetic form of cholesterol that increases the risk of heart disease, and there are currently limited treatment options available.

      Who May Qualify:

      Adults ages 18-80 who:

      • Have a history of cardiovascular disease (heart attack, coronary stent, bypass surgery, stroke, or peripheral artery disease)
      • Have elevated Lp(a) levels (≥175 nmol/L)
      • Have BMI between 18.5 and 40
      • Are on stable heart medications (statins, etc.) for at least 4 weeks
      • Are willing to attend study visits over approximately 2 years

      What to Expect:

      • Receive investigational treatment (investigational treatment) or placebo via subcutaneous injection
      • Three different dosing options: every 26 weeks or every 52 weeks depending on study group
      • Regular study visits for monitoring and assessments
      • Blood tests to measure Lp(a) levels and safety monitoring
      • Extended follow-up period to assess long-term effects
      • All participants eventually receive active treatment (cross-administration design)

      Study Duration:

      Approximately 2 years (104 weeks) total:

      • Prescreening to check Lp(a) levels
      • Screening period (up to 21 days)
      • Treatment period (52 weeks) with regular visits
      • Extended follow-up (up to 52 additional weeks)

      Compensation:

      Participants will receive compensation for their time and participation. All study-related care, procedures, and investigational treatment are provided at no cost.

      Why Participate:

      By participating in this research study, you’ll contribute to important cardiovascular disease research that may help develop new treatments for elevated Lp(a), a genetic risk factor with limited current options. You’ll receive expert study-related medical care and monitoring throughout the study while helping advance treatment options for future patients with elevated Lp(a).

      To learn more about this study and see if you qualify, contact our office or sign up below.

      Study Location: Jacksonville, FL – University Blvd.

      Jacksonville: University Blvd – OCEAN(a)-PreEvent – Lp(a)

       

      Research Study for Heart Disease Now Enrolling!

      Seeking adults who:

      ✅ Are 50 years of age or older
      ✅ Are on a stable dose of cholesterol medication
      ✅ Have been diagnosed with Atherosclerotic Disease OR are at high risk for developing Cardiovascular Disease (risk factors include smoking, high blood pressure requiring medication, & diabetes requiring medication)
      👉 Study-related procedures at no cost. Learn more today!

      Atherosclerotic Disease, often referred to as Atherosclerosis, is a condition where plaque—a mix of fat, cholesterol, and other substances—builds up in your arteries. Over time, this buildup can narrow or block your arteries, making it harder for blood to flow to your heart, brain, and other parts of your body. This can lead to serious health problems like heart attacks, strokes, or poor circulation.

      Why Participate?

      • Potential Access to Cutting Edge Treatments: Be among the first to gain exposure to new therapies under development.
      • Comprehensive Support, No Insurance Required: All study-related care, including lab work and tests, will be provided at no cost to you.
      • Compensation for Time & Travel: We value your contribution and offer compensation for your time, efforts, and travel.
      • Advance Medical Discoveries: Your participation could help improve treatment options for future generations around the world.

      To learn more about this study and see if you qualify, contact our office or sign up below.

      Study Location: Jacksonville, FL – University Blvd.

      Jacksonville: University Blvd – ACCLAIM-CTA – Lp(a)

       

      Study Location: Jacksonville, FL – University Blvd.

      Sign up below and someone from our office will call you with more information.

      Official study website: https://trials.lilly.com/en-US/trial/723885

      Jacksonville: Westside – High Lp(a)

      Study Location: Jacksonville, FL – Westside 904-693-1490

      Sign up below, and someone from our office will call you with more information.

      Nature Coast: Inverness – High Lp(a)

      Join a Research Study for Dyslipidemia with Overnight Stays!

      To qualify, you must:

      • Be 18 to 65 years old
      • Have a BMI between 18 and 35 kg/m2
      • Be in good general health
      • Have high Lp(a) levels

      Please note additional criteria will apply.

      To learn more about this study and see if you qualify, contact our office or sign up below.

      Study Location: Inverness, FL



      This research study is enrolling at:


      Jacksonville Center for Clinical Research
      4085 University Blvd., South
      Suite 1
      Jacksonville, FL 32216
      (904) 730-0166



      Nature Coast Clinical Research – Inverness
      411 West Highland Boulevard
      Inverness, FL 34452
      (352) 341-2100



      Westside Center for Clinical Research
      810 Lane Avenue South
      Jacksonville, FL 32205
      (904) 693-1490



      Fleming Island Center for Clinical Research
      1679 Eagle Harbor Parkway
      Suite D, 2nd Floor Fleming Island, FL 32003
      (904) 621-0390



      Jacksonville Center for Clinical Research
      4085 University Blvd., South
      Suite 1
      Jacksonville, FL 32216
      (904) 730-0166



      St. Johns Center for Clinical Research
      100 Whetstone Place,
      Suites 300 – 301,
      St. Augustine, FL 32086

      (904) 209-0043



      ENCORE Borland Groover Clinical Research
      4800 Belfort Road, Suite 301
      Jacksonville, FL 32256
      (904) 680-0871



      Westside Center for Clinical Research
      810 Lane Avenue South
      Jacksonville, FL 32205
      (904) 693-1490



      Nature Coast Clinical Research – Inverness
      411 West Highland Boulevard
      Inverness, FL 34452
      (352) 341-2100



      Nature Coast Clinical Research – Crystal River
      6122 West Corporate Oaks Drive
      Crystal River, FL 34429
      (352) 861-1865



      Sign up below to join our research studies and make a difference!


      Weight-Loss-1.jpg

      July 27, 2022 Rebecca Simpson


      Are you or someone you know looking to lose weight?

      Qualified volunteers may receive at no cost:

      • Investigational medications

      • Study-related medical care from a qualified doctor

      • Possible compensation for time and travel

      No health insurance is required to participate in our studies.

      View the criteria for each location by clicking the dropdown below, or sign up at the bottom, and our team will contact you directly.



      • Jacksonville: University Blvd – Study (MARITIME-1)
      • Jacksonville: University Blvd – Obesity with T2DM (A-P)
      • Jacksonville: University Blvd – Obesity with or without T2DM (A-P)
      • Jacksonville: University Blvd – NN9833-8420 Overweight/Obesity
      • Jacksonville: University Blvd – Obesity (Adolescents)
      • Jacksonville: University Blvd – AMAZE 7 Obesity
      • Jacksonville: University Blvd – AMAZE 9 Obesity
      • Jacksonville: University Blvd – VESPER-SWITCH – Obesity
      • Jacksonville: Westside – VESPER-SWITCH – Obesity
      • Nature Coast: Crystal River – Obesity/Overweight – VESPER-6
      • Nature Coast: Inverness – Study (REMAIN 1)
      • St. Augustine – Study (MARITIME-ASCVD)
      Jacksonville: University Blvd – Study (MARITIME-1)

      Jacksonville: University Blvd – Obesity with T2DM (A-P)

      The purpose of this study is to find out how safe and effective a study treatment is at helping people with overweight or obesity and type 2 diabetes lose weight, compared to a placebo (a treatment with no active medicine).

      You may be able to participate if you:

      • Have type 2 diabetes
      • Have been on the same diabetes treatment for at least 3 months
      • Have a BMI of 27 or higher (your provider can help calculate this)
      • Have had a stable weight (no more than 5% change) over the past 3 months

      You may not be able to participate if any of the following apply to you:

      Weight Loss Procedures

      • You have had or are planning weight-loss surgery
        (Procedures like liposuction or tummy tuck are okay if done more than 1 year ago)
      • You have had or are planning medical weight-loss devices or procedures
        (Allowed if the device was removed more than 6 months ago)

      Medical Conditions

      • You have type 1 diabetes
      • You have severe heart failure (NYHA Class IV)
      • In the past 3 months, you’ve had:
        • A heart attack
        • A stroke
        • A heart procedure (such as stent or bypass)
        • Unstable chest pain
        • A hospital stay for heart failure
      •  
      •  

      Jacksonville: University Blvd – Obesity with or without T2DM (A-P)

      About this study: 

      This study is looking at a treatment to see how well it works and how safe it is for adults who are overweight or have obesity and do not have type 2 diabetes.

      The study has two parts:

      • Main phase: where participants receive treatment and researchers track things like weight changes and any side effects
      • Extension phase: where participants may continue in the study longer so researchers can understand long-term results and safety

      You may be able to take part if you:

      • Have a BMI of 30 or higher, or27+ with a related health condition (like high blood pressure, high cholesterol, sleep apnea, or heart disease)
      • Have had a stable weight (no major changes) over the past 3 months
      • Have tried dieting in the past without long-term success

      You may not be able to take part if you:

      • Have type 1 or type 2 diabetes
      • Have had recent serious heart problems (like a heart attack or stroke in the past 3 months)
      • Have severe heart failure
      • Have had weight-loss procedures or devices recently
      • Have used weight-loss medications in the past 3 months

      Why participate?

      • Help advance research in heart disease prevention
      • Compensation may be available (if applicable)

      Study Details: 

      Location: Jacksonville, FL 

      All study- related care is provided at no cost to you or your insurance company.

      Jacksonville: University Blvd – NN9833-8420 Overweight/Obesity

      Jacksonville: University Blvd – Obesity (Adolescents)

      Jacksonville: University Blvd – AMAZE 7 Obesity

      Jacksonville: University Blvd – AMAZE 9 Obesity

      Jacksonville: University Blvd – VESPER-SWITCH – Obesity

      The study information below is from Clinicaltrials.gov. https://clinicaltrials.gov/study/NCT07845500?term=vesper-switch&viewType=Card&rank=1#study-overview

      Brief Summary

      The purpose of this study is to learn about the safety and effectiveness of berobenatide in adults with overweight or obesity who have already lost weight while taking semaglutide or tirzepatide. The study does not include people with diabetes.

      Participants will be in the study for about 11 months.

      Eligibility Criteria

      Inclusion Criteria:

      • Aged ≥18 years.
      • Currently taking semaglutide or tirzepatide for obesity management.

      Exclusion Criteria:

      • Diagnosis of any form of diabetes.
      • History of acute or chronic pancreatitis.
      • Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN-2).

      For more information about this study, please visit: https://www.pfizerclinicaltrials.com/nct07845500-weight-management-trial

      Or call our research office.

      Jacksonville: Westside – VESPER-SWITCH – Obesity

      The study information below is from Clinicaltrials.gov. https://clinicaltrials.gov/study/NCT07845500?term=vesper-switch&viewType=Card&rank=1#study-overview

      Brief Summary

      The purpose of this study is to learn about the safety and effectiveness of berobenatide in adults with overweight or obesity who have already lost weight while taking semaglutide or tirzepatide. The study does not include people with diabetes.

      Participants will be in the study for about 11 months.

      Eligibility Criteria

      Inclusion Criteria:

      • Aged ≥18 years.
      • Currently taking semaglutide or tirzepatide for obesity management.

      Exclusion Criteria:

      • Diagnosis of any form of diabetes.
      • History of acute or chronic pancreatitis.
      • Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN-2).

      For more information about this study, please visit: https://www.pfizerclinicaltrials.com/nct07845500-weight-management-trial

      Or call our research office.

      Nature Coast: Crystal River – Obesity/Overweight – VESPER-6

      Are you struggling to manage your weight? Nature Coast Clinical Research – Crystal River is conducting a clinical research study evaluating an investigational once-monthly injection for weight management. The study is enrolling adults who have obesity, or who are overweight with at least one weight-related health condition (such as high blood pressure, high cholesterol, or Type 2 diabetes). Eligible participants will receive study-related care and lifestyle counseling at no cost. Contact us today to learn more and see if you qualify.

      Basic Inclusion Criteria

      • Must be 18 years of age or older.
      • Must have a body mass index (BMI) of 30 or higher (obesity), OR a BMI of 27.0 to less than 30.0 (overweight) with at least one weight-related health condition such as high blood pressure, high cholesterol, sleep apnea, cardiovascular disease, or Type 2 diabetes.
      • Must be motivated to lose at least 20% of your body weight.
      • Must be willing to self-inject the study medication (or have a trained family member or caregiver inject it).
      • Must not have had bariatric or weight loss surgery.
      • Must not have had a weight change greater than 5% in the past 3 months.
      • Must not be currently taking weight loss medications such as Ozempic, Wegovy, Mounjaro, Zepbound, or Saxenda (must have stopped at least 3 months before screening).
      • Must not have had a recent heart attack, stroke, or serious cardiovascular event within the past 3 months.

      Contact Nature Coast Clinical Research – Crystal River to learn more about this clinical trial.

       

      Nature Coast: Inverness – Study (REMAIN 1)

      St. Augustine – Study (MARITIME-ASCVD)

      45+ with a History of Heart Attack or Stroke? 

      You may qualify for a new research study at St. John’s Center for Clinical Research focused on improving the future of cardiovascular care. 

      If you’re living with heart disease, prior heart attack, or stroke, and are also managing weight challenges, this study may be an opportunity to explore new approaches to treatment—while helping advance medical research. 

      About the Study 

      This cardiovascular research study is designed for adults who have experienced a heart attack or stroke and are currently overweight or obese. 

      Researchers are working to better understand how to improve outcomes and develop future treatment options for individuals with cardiovascular conditions. 

      By participating, you’ll play an important role in helping advance heart health research for future generations. 
       Who May Qualify? 

      You may be eligible to participate if you: 

      ✅ Are 45 years of age or older
      ✅ Have a history of heart attack or stroke
      ✅ Have a BMI of 27 or higher(overweight or obese)  

       



      This research is enrolling at:


      Jacksonville Center for Clinical Research
      4085 University Blvd., South
      Suite 1
      Jacksonville, FL 32216
      (904) 730-0166



      St. Johns Center for Clinical Research
      100 Whetstone Place,
      Suites 300 – 301,
      St. Augustine, FL 32086

      (904) 209-0043



      Nature Coast Clinical Research – Crystal River
      6122 West Corporate Oaks Drive
      Crystal River, FL 34429
      (352) 861-1865



      Nature Coast Clinical Research – Inverness
      411 West Highland Boulevard
      Inverness, FL 34452
      (352) 341-2100



      Westside Center for Clinical Research
      810 Lane Avenue South
      Jacksonville, FL 32205
      (904) 693-1490



      BELOW ARE HIDDEN ROWS

      Fleming Island Center for Clinical Research
      1679 Eagle Harbor Parkway
      Suite D, 2nd Floor Fleming Island, FL 32003
      (904) 621-0390



      Jacksonville Center for Clinical Research
      4085 University Blvd., South
      Suite 1
      Jacksonville, FL 32216
      (904) 730-0166



      St. Johns Center for Clinical Research
      100 Whetstone Place,
      Suites 300 – 301,
      St. Augustine, FL 32086

      (904) 209-0043



      ENCORE Borland Groover Clinical Research
      4800 Belfort Road, Suite 301
      Jacksonville, FL 32256
      (904) 680-0871



      Westside Center for Clinical Research
      810 Lane Avenue South
      Jacksonville, FL 32205
      (904) 693-1490



      Nature Coast Clinical Research – Inverness
      411 West Highland Boulevard
      Inverness, FL 34452
      (352) 341-2100



      Nature Coast Clinical Research – Crystal River
      6122 West Corporate Oaks Drive
      Crystal River, FL 34429
      (352) 861-1865



      Sign up below to join our research studies and make a difference!


      Copyright 2023 ENCORE Research Group